EUVIMED · CrossrefZeitschrift
Stem Cell Research
ISSN 1873-5061 · Elsevier BV
Neueste Artikel
Establishment of four induced pluripotent stem cell lines with high polygenic risk score for Parkinson’s disease
Generation of induced pluripotent stem cell lines from two patients with CLIFAHDD syndrome
Characterisation of the patient-specific induced pluripotent stem cell line UKEi075-A carrying the heterozygous PRKAG2 frameshift variant c.769_770del (p.E257Kfs*15)
Generation of an induced pluripotent stem cell line (SCVli192-A) from a patient with immune checkpoint inhibitor-induced myocarditis and concurrent type 1 diabetes
Trophoblast giant cell-like cells differentiated directly from ES cells in vitro recapitulate the copy-number landscape of trophoblast giant cells in vivo
Generation of CD43-P2A-mNeonGreen reporter human pluripotent stem cell line using CRISPR Cas9
Generation of four human induced pluripotent stem cell lines from dermal fibroblasts of healthy female donor
Corrigendum to “Generation of a human induced pluripotent stem cell panel from a family with a heterozygous RPS19 mutation including healthy wild-type, silent carrier and Diamond-Blackfan anemia individuals” [Stem Cell Res. 96 (2026) 104098]
Corrigendum to “Generation and characterization of novel induced pluripotent stem cell (iPSC) lines derived from three symptomatic carriers of a pathogenic MYH11 variant and two non-carrier relatives” [Stem Cell Res. 82 (2025) 103630]
Corrigendum to “Generation of 10 patient-specific induced pluripotent stem cells (iPSCs) to model Pitt-Hopkins Syndrome” [Stem Cell Res. 48 (2020) 102001]
Generation of an induced pluripotent stem cell from a patient with Cornelia de Lange syndrome due to NIPBL mutation
Establishment of an induced pluripotent stem cell (iPSC) line (INNDSUi012-A) from a patient with Spinocerebellar ataxia type 2
Generation of an induced pluripotent stem cell line from a Fabry disease patient carrying the GLA c.640-801G>A mutation
Generation and validation of B2M knockout human iPSC line, LVPEIi001-C-2 that lacks the cell surface expression of HLA-Class I antigens
Generation of a doxycycline-inducible NGN2 iPSC line and a GRIA3-edited iPSC resource
Generation and characterization of a doxycycline-inducible human induced pluripotent stem cell (hiPSC) line for overexpression of connexin 43 (Cx43)
Generation and characterization of induced pluripotent stem cells from patients with Marfan syndrome carrying FBN1 variants
Generation of induced pluripotent stem cell lines from patients with plaque psoriasis and guttate psoriasis
Two iPSC lines with frameshift mutations in FTSJ1 as models for X-linked non-syndromic intellectual disability
Generation of a human induced pluripotent stem cell panel from a family with a heterozygous RPS19 mutation including healthy wild-type, silent carrier and Diamond-Blackfan anemia individuals
CRISPR/Cpf1-mediated editing of DNM1L in induced pluripotent stem cells
Generation and characterization of human iPSC line SANi013-A from a Diamond-Blackfan anemia syndrome (DBAS) patient carrying a heterozygous RPS26 c.95–98 duplication variant
Generation of feeder-free human iPSC lines from a Major depressive disorder patient (MDD) (CHINTAi004-A) and healthy individual (CHINTAi002-A) of Eastern Indian ethnicity
Generation and characterization of fourteen induced pluripotent stem cell (iPSC) lines derived from endometrial stromal fibroblasts of women with polyendocrine metabolic ovarian syndrome (PMOS) (n = 7) and non-PMOS controls (n = 7)
Generation and characterization of two human induced pluripotent stem cell lines from myotonic dystrophy type 1 patients
Ligand-based directed differentiation to produce granulosa-like cells expressing steroidogenic enzyme genes
Generation of two induced pluripotent stem cell lines from female patients harboring MYH7 mutations with hypertrophic cardiomyopathy
Generation of an induced pluripotent stem cell line from a patient with Loeys–Dietz syndrome
Generation of two induced pluripotent stem cell lines from hypertrophic cardiomyopathy patients carrying MYBPC3 mutations
Three donor-matched iPSC lines derived from human postmortem dura mater for modeling neurodegenerative diseases
EUVIMED